-
Document de presse | 2015.01.13
Identification of an Achilles heel in the dengue virus gives new hope for vaccine development
In association with Imperial College London, scientists at the Institut Pasteur and CNRS have identified a vulnerable site on the surface of the dengue virus which is targeted by the only broadly neutralizing antibodies identified to date. This discovery offers a new target for the development of a vaccine to combat all four types of dengue virus currently in circulation. These results were...
-
News | 2017.04.24
Tracking down resistance antimalarials in Cambodia
The malaria molecular epidemiology unit at the Institut Pasteur in Cambodia is interested in the resistance of the malaria pathogens to the drugs currently in use, in particular to the molecular markers making to identify this resistance. Researchers working in this unit have contributed to the identification of a marker associated with resistance to artemisinin in 2014 and one associated with...
-
News | 2020.05.20
Blood test: a potential new tool for controlling infections
A new technique could provide vital information about a community’s immunity to infectious diseases including malaria and Covid-19.The diagnostic test analyses a blood sample to reveal immune markers that indicate whether – and when – a person was exposed to an infection. It was developed to track malaria infections in communities, to assist in the elimination of deadly ‘relapsing’ malaria, but...
-
Document de presse | 2009.05.26
The Institut Pasteur and the U.S. CDC sign a Memorandum of Understanding to promote global public health
The Institut Pasteur and the U.S. Centers for Disease Control and Prevention (CDC) signed a Memorandum of Understanding on the occasion of the Assembly of the World Health Organization (WHO), in Geneva, last week. The agreement unites the efforts of these two organizations – both leaders in the field of global public health – by creating a framework for shared and lasting actions to...
-
News | 2020.11.24
Yellow fever: risk of virus transmission in the Asia-Pacific region
A study, the most comprehensive assessment of vector competence, shows that Aedes aegypti mosquitoes from the Asia-Pacific region are capable of transmitting yellow fever virus. This indicates that vector populations are seemingly not a brake to the emergence of yellow fever in the region.Viral pathogens with high epidemic potential have been historically a major concern for human health. Large-...
-
News | 2021.08.13
Low number of COVID-19 cases in Lao PTR: a seroprevalence study to confirm this figure
In 2020 when many countries around the world struggled with a large burden of COVID-19 cases, the Lao PDR stood out as a country with low reported numbers of SARS-CoV-2 infections. Was it due to a low circulation of the virus or to an inadequate surveillance system? To answer this question, a seroprevalence study has been conducted by Institut Pasteur du Laos, in collaboration with Institut...
-
News | 2023.05.05
40 years of HIV discovery: the first cases of a mysterious disease in the early 1980s
In 1981, the first cases of a completely unknown disease were described in the United States. Plague or gay syndrome, cancer, pneumonia? Rumors were rife. Let’s have an eye back on this story of an emerging disease.
-
Document de presse | 2020.07.27
Malaria: parasite resistance to artemisinin derivatives now affecting Africa
Resistance to artemisinin, the main component of the current antimalarial treatments recommended by WHO, is already widespread in South-East Asia, but it had not previously been described in Africa. Scientists from the Institut Pasteur, in collaboration with the National Malaria Control Program in Rwanda (Rwanda Biomedical Center), the World Health Organization (WHO), Cochin Hospital and Columbia...
-
News | 2020.11.20
Zika outbreaks fostered by virus-permissive mosquitoes
What factors facilitate the emergence of a previously unknown virus in the human population? Scientists from the CNRS, the Institut Pasteur and the IRD, in collaboration with the Institut Pasteur International Network and with several other institutions worldwide, have helped answer that question for the Zika virus. Their study sheds light on regional and continental disparities in Zika...
-
Document de presse | 2016.06.23
Malaria - a mapping of artemisinin resistance confirms that resistance is confined to Southeast Asia and has not spread to sub-Saharan Africa
The first global mapping of artemisinin resistance (the KARMA study) has definitively confirmed that resistance to the main drug currently used in the treatment of Plasmodium falciparum malaria is for the moment confined to Southeast Asia and has not spread to sub–Saharan Africa. Led by researchers from both the Institut Pasteur in Paris and the Institut Pasteur in Cambodia, KARMA gathers a...